Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North



Calendar &
upcoming reports


25 August 2022

Q2 report 2022


7-8 September 2022

Pareto Securities 13th Annual Health Care Conference


24 November 2022

Q3 report 2022


7-9 January 2023

Presentation on SEB Nordic Seminar



Show all posts